Recent years have seen an increase in studies exploring the roles of CX3CL1/CX3CR1 signaling in aging-related neurodegenerative diseases, including AD and PD (Pawelec et al., 2020). This evidence concerns the gene CX3CL1 and Alzheimer disease.